Stock Market Analysis News 17 December 2025

Enbridge gets a fresh 15-to-1 “scalable risk” setup as Stock Traders Daily posts new AI signals

NEW YORK, December 29, 2025, 10:59 ET Stock Traders Daily early on Dec. 29 published a trading-setup note on Enbridge Inc (ENB), citing an “exceptional 15.2:1” risk-reward profile for the Canadian pipeline operator’s shares. Stock Traders Daily+1 The note matters

29 December 2025

Financial News·Investment Strategies·Risk Management·Stock Market Analysis

Rare Metals Stocks Outlook: Silver’s Record Run, Lithium Demand Warning, and Rare Earth Supply Chains in Focus Before Monday’s Open

NEW YORK, Dec. 28, 2025, 12:42 PM ET — Market Closed U.S. equity markets are closed Sunday, leaving investors in rare metals stocks—from rare earths and graphite to lithium, antimony, silver, and platinum group metals—to digest a headline-heavy stretch that

28 December 2025

Investment Trends·Lithium Industry·Precious Metals·Stock Market Analysis

Semiconductor Stocks Outlook: Memory Chip Shortage, AI Spending Debate, and What to Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 12:37 p.m. ET — Market closed. U.S. stock markets are shut for the weekend, leaving semiconductor stocks in a familiar year-end spotlight: investors are weighing bullish AI-driven demand against fresh supply-chain strain and renewed questions

28 December 2025

AI Technology·Investment Insights·Market Trends·Semiconductor Industry·Stock Market Analysis

Natural Gas Prices Rise Again as Colder Forecasts Return — What Henry Hub, LNG Exports, Storage Data and Today’s Stock Market Mood Mean for Investors

New York time check: It is 1:31 p.m. ET on Friday, December 26, 2025 in New York. U.S. natural gas is back in the spotlight as winter weather risk re-enters the conversation, even while Wall Street trades in a post-holiday

26 December 2025

Commodity Prices·Energy Markets·Investment Strategies·Natural Gas·Stock Market Analysis

Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

December 25, 2025 — Intuitive Surgical, Inc. (NASDAQ: ISRG) is ending 2025 with two storylines that rarely move in sync: fresh regulatory momentum for its single-port robotic platform and a renewed valuation debate as analysts model what the next wave

25 December 2025

FDA Approvals·Investment Insights·Medical Technology·Stock Market Analysis

Applied Materials (AMAT) News and 2026 Outlook on Dec. 25, 2025: Record FY2025, China Export Curbs, Dividend, and Wall Street Forecasts

December 25, 2025 (Thursday) — Applied Materials, Inc. is closing out the year with a familiar paradox: strong financial performance driven by AI-era semiconductor demand, paired with real policy-driven friction tied to U.S.-China export controls. With U.S. equity markets closed

25 December 2025

Company Earnings·Global Trade·Investment Strategies·Semiconductor Industry·Stock Market Analysis

Wells Fargo (WFC) News on Dec. 25, 2025: Options Clearing Expansion, Investment Banking Push, and 2026 Outlook After Asset Cap Lift

As the U.S. banking sector heads into year-end, Wells Fargo & Company (NYSE: WFC) is closing 2025 with a noticeably different narrative than the one investors and regulators have debated for much of the past decade: less about constraint, more

25 December 2025

Banking News·Economic Outlook·Financial Regulation·Investment Strategies·Stock Market Analysis

Adobe Stock Forecast: ADBE Holds Near $354 on Dec. 24, 2025 as AI Monetization, Semrush Deal, and Valuation Debate Intensify

December 24, 2025 — Adobe Inc. (NASDAQ: ADBE) is ending the holiday-shortened Christmas Eve session in focus, as investors weigh two competing narratives: a high-margin software leader guiding to another year of growth — and a creative franchise facing louder

24 December 2025

Financial News·Investment Strategies·Stock Market Analysis·Technology Stocks

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (NASDAQ: FOLD) is no longer trading like a “typical biotech story stock.” After BioMarin’s all-cash $14.50-per-share takeover agreement, FOLD has effectively become a deal-driven, merger-arbitrage name—meaning next week’s action is likely

22 December 2025

Biotech Stocks·Investment News·Mergers and Acquisitions·Pharmaceutical Industry·Stock Market Analysis

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

December 20, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” to a merger-arbitrage stock after BioMarin Pharmaceutical announced a definitive, all-cash acquisition valued at roughly $4.8 billion. The headline number for shareholders: $14.50

20 December 2025

Biotech Stocks·Investment Strategies·Mergers & Acquisitions·Pharma News·Stock Market Analysis

Real Estate Stocks Outlook for 2026: REITs, Homebuilders, and PropTech Reset After December Rate Cuts

Dec. 20, 2025 — Real estate stocks are heading into 2026 with a familiar catalyst back in the driver’s seat: interest rates. After the Federal Reserve lowered the federal funds target range by 25 basis points to 3.5%–3.75% at its

20 December 2025

REITs·Stock Market Analysis

Micron Earnings Preview: Surging Memory Chip Prices Put MU Stock in the Spotlight After Broadcom and Oracle’s AI Selloff

December 17, 2025 — Micron Technology (NASDAQ: MU) is stepping into one of the most closely watched earnings prints in the semiconductor sector this quarter, as investors look for a clear read on two forces tugging the market in opposite

17 December 2025

AI Technology·Earnings Preview·Investment Insights·Semiconductor Industry·Stock Market Analysis

Stock Market Analysis News 17 December 2025 - 29 December 2025